EPAD webinar by KNect365 is now available
As part of the Clinical Trials Digital Week, KNect365 Life Sciences organised a global 4-day
As part of the Clinical Trials Digital Week, KNect365 Life Sciences organised a global 4-day
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
The European Prevention of Alzheimer’s Dementia (EPAD) project, a highly innovative programme aiming to streamline
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
Neuronet’s communication team and our community of communication representatives are pleased to announce that we will celebrate our projects.
The EPAD project, originally scheduled to end in December 2019, has been extended setting the end date in June 2020.
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.
The EPAD Longitudinal Cohort Study has recruited its 1,000th participant at the University of Oxford (UK).